Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Aditya V. Shreenivas"'
Autor:
Sewanti Limaye, Mohan Menon, Shambhavi Singh, Pritam Kataria, Aditya V. Shreenivas, Rajan Datar, Darshana Patil, Prashant Kumar, Niyati Shah, Hardik Sheth, Suku Sneha, Chetan Madre, Ruturaj Deshpande, Narayan K. Menon, Prasad Dandekar, Vijay Haribhakti
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 7, Iss 3, Pp 171-177 (2024)
Externí odkaz:
https://doaj.org/article/ce0a692af1a740f8a75c22fdae69b2d7
Autor:
James C. Gates, Allison P. Clark, Elliot Cherkas, Aditya V. Shreenivas, Dennis Kraus, Natalie Danzinger, Richard S. P. Huang, Jennifer Johnson, Jeffrey S. Ross
Publikováno v:
Head & Neck. 45:816-826
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e0e37e1788ad0da4f161f3675d472a5
https://doi.org/10.1002/hed.27294
https://doi.org/10.1002/hed.27294
Autor:
Aditya V. Shreenivas, Shumei Kato, Jingjing Hu, Catherine Skefos, Jason Sicklick, Razelle Kurzrock
Publikováno v:
CA Cancer J Clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d8d34c7dfafcaec4c9f4535f4adad86
https://doi.org/10.3322/caac.21748
https://doi.org/10.3322/caac.21748
Publikováno v:
Journal of Clinical Oncology. 41:89-89
89 Background: Enterocolitis is a potentially fatal toxicity of CAPE. The safety of infusional 5-FU-based regimens in patients developing severe enterocolitis with CAPE is not well established in the literature. Methods: After institutional review bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a22106b630c4b8670ceb78aaa38b489
https://doi.org/10.1200/jco.2023.41.4_suppl.89
https://doi.org/10.1200/jco.2023.41.4_suppl.89
Autor:
Maahum Mehdi, Bicky Thapa, Aniko Szabo, Gulrayz Ahmed, Aditya V. Shreenivas, James P. Thomas, Deepika Sriram, Douglas B. Evans, Susan Tsai, Kathleen K. Christians, Beth Erickson, William A. Hall, Thomas McFall, Steve Patrick, Ben George, Razelle Kurzrock, Mandana Kamgar
Publikováno v:
Journal of Clinical Oncology. 41:754-754
754 Background: ATM and CHEK2 mutations are linked to homologous recombination DNA repair deficiency, with the potential for improved therapeutic response to DNA damaging agents. To investigate our clinical observation of improved outcomes with irino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96217099535bae23a3e44a0266e92b05
https://doi.org/10.1200/jco.2023.41.4_suppl.754
https://doi.org/10.1200/jco.2023.41.4_suppl.754
Autor:
Sakti Chakrabarti, Marie Parish, Carrie Peterson, Kirk A. Ludwig, Deepika Sriram, Antony Ruggeri, Sameer Tolay, Jennifer Eva Selfridge, David L Bajor, Amr Mohamed, Amit Mahipal, Aditya V. Shreenivas
Publikováno v:
Journal of Clinical Oncology. 41:105-105
105 Background: Patients with potentially resectable dMMR/MSI-H colon cancer (CC) often receive neoadjuvant immunotherapy (IO) if co-morbid conditions or the extent of disease preclude upfront surgery. We investigated the outcome of such patients tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9477b1b98e3882bcd5f08aa83f6205d
https://doi.org/10.1200/jco.2023.41.4_suppl.105
https://doi.org/10.1200/jco.2023.41.4_suppl.105
Autor:
Emilee McCullough, Aditya V. Shreenivas, Stephanie Spitzer, Michelle Schroeder, Aniko Szabo, David Friedland, Stuart J. Wong
Publikováno v:
Journal of Clinical Oncology. 40:192-192
192 Background: Ototoxicity is a common and treatment-limiting side effect of cisplatin. Rates of permanent hearing loss due to cisplatin treatment range from 40 to 80% and are associated with considerable morbidity and negative impact on quality of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::900341fc07ce1edf5bdb3877469ff6c1
https://doi.org/10.1200/jco.2022.40.28_suppl.192
https://doi.org/10.1200/jco.2022.40.28_suppl.192
Autor:
Aditya V. Shreenivas, Jared Robbins, Yi Hu, Santhosh Yegnaraman, Sergey Tarima, Alexander V. Ng, Nicole Moore, Lauren Opielinski, Stuart J. Wong
Publikováno v:
Journal of Clinical Oncology. 40:420-420
420 Background: Oral Mucositis related pain is one of the most common radiation therapy (RT) related toxicities associated with the treatment of head and neck cancer (HNC). Questionnaire-based assessment of mucositis pain is based on a patient's reca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91435147b8e0d3d7b0f33d1ceb0e84d6
https://doi.org/10.1200/jco.2022.40.28_suppl.420
https://doi.org/10.1200/jco.2022.40.28_suppl.420
Autor:
Aditya V. Shreenivas, Seth M. Cohen
Publikováno v:
Mount Sinai Expert Guides. :56-65
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74f71b651bbb8f4b3762e503060e4a26
https://doi.org/10.1002/9781119189596.ch5
https://doi.org/10.1002/9781119189596.ch5
Autor:
Thomas Matoska, Lauren Jurkowski, Anjishnu Banerjee, Aditya V. Shreenivas, Monica Shukla, Enrique Martinez, Divya Kodali, Paul Linsky, Mario Gasparri, Sakti Chakrabarti, Ben George, Elizabeth Gore, Candice Aitken Johnstone, David Johnstone, Lindsay Puckett
Publikováno v:
Journal of Clinical Oncology. 40:e16072-e16072
e16072 Background: The SEER 5-year overall survival rate for all stages of esophageal cancer (EC) was 25% in 2019. Definitive chemoradiation (CRT) remains the primary treatment approach for locally advanced EC in the US, however, there are data to su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f34d700ae864028e8cf4f3c23bed48e
https://doi.org/10.1200/jco.2022.40.16_suppl.e16072
https://doi.org/10.1200/jco.2022.40.16_suppl.e16072